INTERNATIONAL PATENT: BETH ISRAEL DEACONESS MEDICAL CENTER, INC. FILES APPLICATION FOR "(1H-INDOL-3-YL)(PYRIDIN-2-YL)METHANONE DERIVATIVES AS ARYL HYDROCARBON RECEPTOR (AHR) AGONISTS FOR THE TREATMENT OF INFLAMMATORY, AUTOIMMUNE, METABOLIC OR PROLIFERATIVE DISEASES"

GENEVA, Feb. 18 -- BETH ISRAEL DEACONESS MEDICAL CENTER, INC. (330 Brookline AvenueBoston, MA 02215) filed a patent application (PCT/US2025/041259) for "(1H-INDOL-3-YL)(PYRIDIN-2-YL)METHANONE DERIVATIVES AS ARYL HYDROCARBON RECEPTOR (AHR) AGONISTS FOR THE TREATMENT OF INFLAMMATORY, AUTOIMMUNE, METABOLIC OR PROLIFERATIVE DISEASES" on Aug 08, 2025. With publication no. WO/2026/036026, the details related to the patent application was published on Feb 12, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): SUN, Lijun (148 Depot RoadHarvard, MA 01451), CHAIKOF, Elliot (165 Bigelow RoadNewton, MA 024...